Literature DB >> 1378890

A neuroendocrine cause of oncogenic osteomalacia.

M D Stone1, C Quincey, D J Hosking.   

Abstract

All definite cases of oncogenic osteomalacia have, until now, been classified as mesenchymal tumours. We report here a case of oncogenic osteomalacia caused by a spinal tumour. Microscopically, it resembled the mixed connective tissue variant of previously described phosphaturic tumours. Immunohistochemical studies, however, showed the tumour cells to be positive for low molecular weight cytokeratin (CAM 5.2), S100 protein, PGP 9.5, and synaptophysin. Electron microscopy demonstrated neurosecretory granules. The histopathological findings strongly suggest that this is a neuroendocrine tumour.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1378890     DOI: 10.1002/path.1711670204

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  8 in total

Review 1.  Tumor-induced osteomalacia.

Authors:  William H Chong; Alfredo A Molinolo; Clara C Chen; Michael T Collins
Journal:  Endocr Relat Cancer       Date:  2011-06-08       Impact factor: 5.678

Review 2.  Tumor-Induced Osteomalacia: an Up-to-Date Review.

Authors:  Anke H Hautmann; Matthias G Hautmann; Oliver Kölbl; Wolfgang Herr; Martin Fleck
Journal:  Curr Rheumatol Rep       Date:  2015-06       Impact factor: 4.592

3.  Secondary hyperparathyroidism as a palpable intrathyroid parathyroid gland in a patient with hypophosphatemic osteomalacia.

Authors:  Deng-Huang Su; Kuo-Meng Liao; Ying-Chun Chang; Keh-Sung Tsai
Journal:  J Bone Miner Metab       Date:  2006       Impact factor: 2.626

Review 4.  En bloc resection for treatment of tumor-induced osteomalacia: a case presentation and a systematic review.

Authors:  Tong Meng; Wang Zhou; Bo Li; Huabin Yin; Zhenxi Li; Lei Zhou; Jinhai Kong; Wangjun Yan; Xinghai Yang; Tielong Liu; Dianwen Song; Jianru Xiao
Journal:  World J Surg Oncol       Date:  2015-05-08       Impact factor: 2.754

Review 5.  En Bloc Resection of Solitary Functional Secreting Spinal Metastasis.

Authors:  C Rory Goodwin; Michelle J Clarke; Ziya L Gokaslan; Charles Fisher; Ilya Laufer; Michael H Weber; Daniel M Sciubba
Journal:  Global Spine J       Date:  2015-07-16

6.  Tumor-induced osteomalacia caused by primary fibroblast growth factor 23 secreting neoplasm in axial skeleton: a case report.

Authors:  Gunjan Y Gandhi; Aashish A Shah; Kevin J Wu; Vivek Gupta; Ali Reza Shoraka
Journal:  Case Rep Endocrinol       Date:  2012-12-17

7.  Oncogenic osteomalacia as a harbinger of recurrent osteosarcoma.

Authors:  E B Lamont; M K Cavaghan; B E Brockstein
Journal:  Sarcoma       Date:  1999

8.  Tumor-Induced Osteomalacia: Increased Level of FGF-23 in a Patient with a Phosphaturic Mesenchymal Tumor at the Tibia Expressing Periostin.

Authors:  Anke H Hautmann; Josef Schroeder; Peter Wild; Matthias G Hautmann; Elisabeth Huber; Patrick Hoffstetter; Martin Fleck; Christiane Girlich
Journal:  Case Rep Endocrinol       Date:  2014-08-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.